Home/Filings/4/0001017632-06-000001
4//SEC Filing

OMARA JOHN M 4

Accession 0001017632-06-000001

CIK 0000009346other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 2:06 PM ET

Size

17.7 KB

Accession

0001017632-06-000001

Insider Transaction Report

Form 4
Period: 2006-01-02
OMARA JOHN M
Director
Transactions
  • Exercise/Conversion

    Class B Common

    2006-01-02$24.30/sh+932$22,64867,108 total
  • Award

    Right to buy (option)

    2005-04-01$25.36/sh+267$6,771267 total
    Exercise: $1.00From: 2006-04-03Exp: 2015-04-02Class B Common (267 underlying)
  • Award

    Right to buy (option)

    2005-05-03$25.71/sh+1,500$38,5651,500 total
    Exercise: $25.71From: 2006-05-03Exp: 2012-05-03Class B Common (1,500 underlying)
  • Exercise of In-Money

    Right to buy (option)

    2006-01-02$24.30/sh932$22,6485,976 total
    Exercise: $0.80From: 1996-01-03Exp: 2013-01-03Class B Common (932 underlying)
Holdings
  • Class A Common

    14,062
  • Class A Common

    (indirect: By Trust)
    57,375
  • Class A Common

    (indirect: By Spouse)
    13,875
  • Right to buy (option)

    Exercise: $1.00From: 2004-04-02Exp: 2015-01-03Class B Common (1,706 underlying)
    1,706
  • Right to buy (option)

    Exercise: $26.00From: 2005-05-04Exp: 2011-05-04Class B Common (1,500 underlying)
    1,500
Footnotes (5)
  • [F1]Reporting person serves as trustee and has or shares investment power but expressly disclaims beneficial ownership.
  • [F2]Reporting person disclaims beneficial ownership of these shares.
  • [F3]Options become exercisable one year from the date of issuance and expire ten years and one day from the date of issuance. Exercise price for all options was $1.00 per share on the date of grant (subsequently adjusted for 5-for-4 stock split). For options previously reported on Forms 4 and 5, the expiration dates range from January 3, 2006 to January 3, 2013. The price paid for the options was equal to and in lieu of directors fees.
  • [F4]Options become exercisable one year from the date of issuance and expire ten years and one day from the date of issuance. Exercise price for all options was $1.00 per share on the date of grant. For options previously reported on Forms 4 and 5, the expiration dates range from April 3, 2013 to January 3, 2015. The price paid for the options was equal to and in lieu of directors fees.
  • [F5]The price paid for the options was equal to and in lieu of directors fees.

Issuer

BALDWIN & LYONS INC

CIK 0000009346

Entity typeother

Related Parties

1
  • filerCIK 0001017632

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 2:06 PM ET
Size
17.7 KB